A Global Registry Aims to See if COVID-19 Causes Diabetes

Researchers have collected hundreds of COVID-19–related diabetes case reports since August of last year, in hopes of teasing apart the complex links between the two diseases.

Written byAsher Jones
| 2 min read
diabetes, type 1, type 2, COVID-19, SARS-CoV-2, coronavirus, pandemic, registry

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ABOVE: © ISTOCK.COM, TEMPURA

Type 1 and 2 diabetes are among the pre-existing conditions associated with more-severe COVID-19 and a greater risk of death from the infection. A growing number of reports have also linked coronavirus infections with new cases of diabetes, prompting researchers to investigate the possibility that SARS-CoV-2 triggers the metabolic disease.

To answer some of the questions about how the two diseases influence each other, researchers from King’s College London and Monash University in Australia established the COVIDIAB registry last year to compile detailed reports of COVID-19–related diabetes. According to The Guardian, about 350 clinicians have submitted reports to date.

“The relationship between COVID-19 and diabetes is very complex,” Francesco Rubino, the chair of metabolic and bariatric surgery at King’s College London and one of the researchers who started the registry, tells Scientific American. “It might involve more than one issue.”

A meta-analysis of more than 3,700 ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies